XML 21 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid In Capital [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 4,323 $ 165,396,036 $ (13,093) $ (162,078,525) $ 3,308,741
Balance (in shares) at Dec. 31, 2018 432,286        
Public offering of common stock and warrants, net of issuance costs $ 4,500 4,778,009 4,782,509
Public offering of common stock and warrants, net of issuance costs (in shares) 450,000        
Stock compensation expense 98,033 98,033
Foreign currency translation 2,826 2,826
Net loss (3,853,116) (3,853,116)
Balance at Mar. 31, 2019 $ 8,823 170,272,078 (10,267) (165,931,641) 4,338,993
Balance (in shares) at Mar. 31, 2019 882,286        
Balance at Dec. 31, 2019 $ 55,823 178,779,814 (17,315) (174,524,983) 4,293,339
Balance (in shares) at Dec. 31, 2019 5,582,280        
At the market offering, net of offering costs $ 28,149 5,449,283 5,477,432
At the market offering, net of offering costs, shares 2,814,934        
Common stock warrant exercises $ 40,710 8,101,290 8,142,000
Common stock warrant exercises, shares 4,071,000        
Stock compensation expense 79,740 79,740
Foreign currency translation 39,477 39,477
Net loss     (3,949,294) (3,949,294)
Balance at Mar. 31, 2020 $ 124,682 $ 192,410,127 $ 22,162 $ (178,474,277) $ 14,082,694
Balance (in shares) at Mar. 31, 2020 12,468,214